The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Cancer Genome Analysis Market Research Report 2025

Global Cancer Genome Analysis Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1946437

No of Pages : 101

Ask Your Query
Synopsis
The global Cancer Genome Analysis market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Cancer Genome Analysis is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Cancer Genome Analysis is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Cancer Genome Analysis in Clinical is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Cancer Genome Analysis include Abbott Diagnostics, AccuraGen Inc, Acuamark Diagnostics, Admera Health, LLC, Agena Bioscience, Inc, Agilent, Almac Diagnostics, Amoy Diagnostics Co., Ltd. and Anchor Dx, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cancer Genome Analysis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Genome Analysis.
Report Scope
The Cancer Genome Analysis market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cancer Genome Analysis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Genome Analysis companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Diagnostics
AccuraGen Inc
Acuamark Diagnostics
Admera Health, LLC
Agena Bioscience, Inc
Agilent
Almac Diagnostics
Amoy Diagnostics Co., Ltd.
Anchor Dx
ANGLE plc
ApoCell, Inc.
ArcherDx, Inc
Asuragen
AVIVA Biosciences
Baylor Miraca Genetics Laboratories
Beckman Coulter, Inc.
Becton, Dickinson and Company
BGI Genomics Co. Ltd
Bioarray Genetics
Biocartis
Biocept, Inc
Biodesix Inc
BioFluidica
bioMérieux Diagnostics
Bioneer Corporation
Bio-Rad Laboratories, Inc
Bio-Techne
Segment by Type
Solid Tissue Analysis
Liquid Tissue Analysis
Segment by Application
Clinical
Pharmaceutical
Research
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Genome Analysis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Genome Analysis Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Solid Tissue Analysis
1.2.3 Liquid Tissue Analysis
1.3 Market by Application
1.3.1 Global Cancer Genome Analysis Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Clinical
1.3.3 Pharmaceutical
1.3.4 Research
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Genome Analysis Market Perspective (2019-2030)
2.2 Cancer Genome Analysis Growth Trends by Region
2.2.1 Global Cancer Genome Analysis Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cancer Genome Analysis Historic Market Size by Region (2019-2024)
2.2.3 Cancer Genome Analysis Forecasted Market Size by Region (2025-2030)
2.3 Cancer Genome Analysis Market Dynamics
2.3.1 Cancer Genome Analysis Industry Trends
2.3.2 Cancer Genome Analysis Market Drivers
2.3.3 Cancer Genome Analysis Market Challenges
2.3.4 Cancer Genome Analysis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Genome Analysis Players by Revenue
3.1.1 Global Top Cancer Genome Analysis Players by Revenue (2019-2024)
3.1.2 Global Cancer Genome Analysis Revenue Market Share by Players (2019-2024)
3.2 Global Cancer Genome Analysis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cancer Genome Analysis Revenue
3.4 Global Cancer Genome Analysis Market Concentration Ratio
3.4.1 Global Cancer Genome Analysis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Genome Analysis Revenue in 2023
3.5 Cancer Genome Analysis Key Players Head office and Area Served
3.6 Key Players Cancer Genome Analysis Product Solution and Service
3.7 Date of Enter into Cancer Genome Analysis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Genome Analysis Breakdown Data by Type
4.1 Global Cancer Genome Analysis Historic Market Size by Type (2019-2024)
4.2 Global Cancer Genome Analysis Forecasted Market Size by Type (2025-2030)
5 Cancer Genome Analysis Breakdown Data by Application
5.1 Global Cancer Genome Analysis Historic Market Size by Application (2019-2024)
5.2 Global Cancer Genome Analysis Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cancer Genome Analysis Market Size (2019-2030)
6.2 North America Cancer Genome Analysis Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cancer Genome Analysis Market Size by Country (2019-2024)
6.4 North America Cancer Genome Analysis Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer Genome Analysis Market Size (2019-2030)
7.2 Europe Cancer Genome Analysis Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cancer Genome Analysis Market Size by Country (2019-2024)
7.4 Europe Cancer Genome Analysis Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Genome Analysis Market Size (2019-2030)
8.2 Asia-Pacific Cancer Genome Analysis Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cancer Genome Analysis Market Size by Region (2019-2024)
8.4 Asia-Pacific Cancer Genome Analysis Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer Genome Analysis Market Size (2019-2030)
9.2 Latin America Cancer Genome Analysis Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cancer Genome Analysis Market Size by Country (2019-2024)
9.4 Latin America Cancer Genome Analysis Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Genome Analysis Market Size (2019-2030)
10.2 Middle East & Africa Cancer Genome Analysis Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cancer Genome Analysis Market Size by Country (2019-2024)
10.4 Middle East & Africa Cancer Genome Analysis Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Diagnostics
11.1.1 Abbott Diagnostics Company Detail
11.1.2 Abbott Diagnostics Business Overview
11.1.3 Abbott Diagnostics Cancer Genome Analysis Introduction
11.1.4 Abbott Diagnostics Revenue in Cancer Genome Analysis Business (2019-2024)
11.1.5 Abbott Diagnostics Recent Development
11.2 AccuraGen Inc
11.2.1 AccuraGen Inc Company Detail
11.2.2 AccuraGen Inc Business Overview
11.2.3 AccuraGen Inc Cancer Genome Analysis Introduction
11.2.4 AccuraGen Inc Revenue in Cancer Genome Analysis Business (2019-2024)
11.2.5 AccuraGen Inc Recent Development
11.3 Acuamark Diagnostics
11.3.1 Acuamark Diagnostics Company Detail
11.3.2 Acuamark Diagnostics Business Overview
11.3.3 Acuamark Diagnostics Cancer Genome Analysis Introduction
11.3.4 Acuamark Diagnostics Revenue in Cancer Genome Analysis Business (2019-2024)
11.3.5 Acuamark Diagnostics Recent Development
11.4 Admera Health, LLC
11.4.1 Admera Health, LLC Company Detail
11.4.2 Admera Health, LLC Business Overview
11.4.3 Admera Health, LLC Cancer Genome Analysis Introduction
11.4.4 Admera Health, LLC Revenue in Cancer Genome Analysis Business (2019-2024)
11.4.5 Admera Health, LLC Recent Development
11.5 Agena Bioscience, Inc
11.5.1 Agena Bioscience, Inc Company Detail
11.5.2 Agena Bioscience, Inc Business Overview
11.5.3 Agena Bioscience, Inc Cancer Genome Analysis Introduction
11.5.4 Agena Bioscience, Inc Revenue in Cancer Genome Analysis Business (2019-2024)
11.5.5 Agena Bioscience, Inc Recent Development
11.6 Agilent
11.6.1 Agilent Company Detail
11.6.2 Agilent Business Overview
11.6.3 Agilent Cancer Genome Analysis Introduction
11.6.4 Agilent Revenue in Cancer Genome Analysis Business (2019-2024)
11.6.5 Agilent Recent Development
11.7 Almac Diagnostics
11.7.1 Almac Diagnostics Company Detail
11.7.2 Almac Diagnostics Business Overview
11.7.3 Almac Diagnostics Cancer Genome Analysis Introduction
11.7.4 Almac Diagnostics Revenue in Cancer Genome Analysis Business (2019-2024)
11.7.5 Almac Diagnostics Recent Development
11.8 Amoy Diagnostics Co., Ltd.
11.8.1 Amoy Diagnostics Co., Ltd. Company Detail
11.8.2 Amoy Diagnostics Co., Ltd. Business Overview
11.8.3 Amoy Diagnostics Co., Ltd. Cancer Genome Analysis Introduction
11.8.4 Amoy Diagnostics Co., Ltd. Revenue in Cancer Genome Analysis Business (2019-2024)
11.8.5 Amoy Diagnostics Co., Ltd. Recent Development
11.9 Anchor Dx
11.9.1 Anchor Dx Company Detail
11.9.2 Anchor Dx Business Overview
11.9.3 Anchor Dx Cancer Genome Analysis Introduction
11.9.4 Anchor Dx Revenue in Cancer Genome Analysis Business (2019-2024)
11.9.5 Anchor Dx Recent Development
11.10 ANGLE plc
11.10.1 ANGLE plc Company Detail
11.10.2 ANGLE plc Business Overview
11.10.3 ANGLE plc Cancer Genome Analysis Introduction
11.10.4 ANGLE plc Revenue in Cancer Genome Analysis Business (2019-2024)
11.10.5 ANGLE plc Recent Development
11.11 ApoCell, Inc.
11.11.1 ApoCell, Inc. Company Detail
11.11.2 ApoCell, Inc. Business Overview
11.11.3 ApoCell, Inc. Cancer Genome Analysis Introduction
11.11.4 ApoCell, Inc. Revenue in Cancer Genome Analysis Business (2019-2024)
11.11.5 ApoCell, Inc. Recent Development
11.12 ArcherDx, Inc
11.12.1 ArcherDx, Inc Company Detail
11.12.2 ArcherDx, Inc Business Overview
11.12.3 ArcherDx, Inc Cancer Genome Analysis Introduction
11.12.4 ArcherDx, Inc Revenue in Cancer Genome Analysis Business (2019-2024)
11.12.5 ArcherDx, Inc Recent Development
11.13 Asuragen
11.13.1 Asuragen Company Detail
11.13.2 Asuragen Business Overview
11.13.3 Asuragen Cancer Genome Analysis Introduction
11.13.4 Asuragen Revenue in Cancer Genome Analysis Business (2019-2024)
11.13.5 Asuragen Recent Development
11.14 AVIVA Biosciences
11.14.1 AVIVA Biosciences Company Detail
11.14.2 AVIVA Biosciences Business Overview
11.14.3 AVIVA Biosciences Cancer Genome Analysis Introduction
11.14.4 AVIVA Biosciences Revenue in Cancer Genome Analysis Business (2019-2024)
11.14.5 AVIVA Biosciences Recent Development
11.15 Baylor Miraca Genetics Laboratories
11.15.1 Baylor Miraca Genetics Laboratories Company Detail
11.15.2 Baylor Miraca Genetics Laboratories Business Overview
11.15.3 Baylor Miraca Genetics Laboratories Cancer Genome Analysis Introduction
11.15.4 Baylor Miraca Genetics Laboratories Revenue in Cancer Genome Analysis Business (2019-2024)
11.15.5 Baylor Miraca Genetics Laboratories Recent Development
11.16 Beckman Coulter, Inc.
11.16.1 Beckman Coulter, Inc. Company Detail
11.16.2 Beckman Coulter, Inc. Business Overview
11.16.3 Beckman Coulter, Inc. Cancer Genome Analysis Introduction
11.16.4 Beckman Coulter, Inc. Revenue in Cancer Genome Analysis Business (2019-2024)
11.16.5 Beckman Coulter, Inc. Recent Development
11.17 Becton, Dickinson and Company
11.17.1 Becton, Dickinson and Company Company Detail
11.17.2 Becton, Dickinson and Company Business Overview
11.17.3 Becton, Dickinson and Company Cancer Genome Analysis Introduction
11.17.4 Becton, Dickinson and Company Revenue in Cancer Genome Analysis Business (2019-2024)
11.17.5 Becton, Dickinson and Company Recent Development
11.18 BGI Genomics Co. Ltd
11.18.1 BGI Genomics Co. Ltd Company Detail
11.18.2 BGI Genomics Co. Ltd Business Overview
11.18.3 BGI Genomics Co. Ltd Cancer Genome Analysis Introduction
11.18.4 BGI Genomics Co. Ltd Revenue in Cancer Genome Analysis Business (2019-2024)
11.18.5 BGI Genomics Co. Ltd Recent Development
11.19 Bioarray Genetics
11.19.1 Bioarray Genetics Company Detail
11.19.2 Bioarray Genetics Business Overview
11.19.3 Bioarray Genetics Cancer Genome Analysis Introduction
11.19.4 Bioarray Genetics Revenue in Cancer Genome Analysis Business (2019-2024)
11.19.5 Bioarray Genetics Recent Development
11.20 Biocartis
11.20.1 Biocartis Company Detail
11.20.2 Biocartis Business Overview
11.20.3 Biocartis Cancer Genome Analysis Introduction
11.20.4 Biocartis Revenue in Cancer Genome Analysis Business (2019-2024)
11.20.5 Biocartis Recent Development
11.21 Biocept, Inc
11.21.1 Biocept, Inc Company Detail
11.21.2 Biocept, Inc Business Overview
11.21.3 Biocept, Inc Cancer Genome Analysis Introduction
11.21.4 Biocept, Inc Revenue in Cancer Genome Analysis Business (2019-2024)
11.21.5 Biocept, Inc Recent Development
11.22 Biodesix Inc
11.22.1 Biodesix Inc Company Detail
11.22.2 Biodesix Inc Business Overview
11.22.3 Biodesix Inc Cancer Genome Analysis Introduction
11.22.4 Biodesix Inc Revenue in Cancer Genome Analysis Business (2019-2024)
11.22.5 Biodesix Inc Recent Development
11.23 BioFluidica
11.23.1 BioFluidica Company Detail
11.23.2 BioFluidica Business Overview
11.23.3 BioFluidica Cancer Genome Analysis Introduction
11.23.4 BioFluidica Revenue in Cancer Genome Analysis Business (2019-2024)
11.23.5 BioFluidica Recent Development
11.24 bioMérieux Diagnostics
11.24.1 bioMérieux Diagnostics Company Detail
11.24.2 bioMérieux Diagnostics Business Overview
11.24.3 bioMérieux Diagnostics Cancer Genome Analysis Introduction
11.24.4 bioMérieux Diagnostics Revenue in Cancer Genome Analysis Business (2019-2024)
11.24.5 bioMérieux Diagnostics Recent Development
11.25 Bioneer Corporation
11.25.1 Bioneer Corporation Company Detail
11.25.2 Bioneer Corporation Business Overview
11.25.3 Bioneer Corporation Cancer Genome Analysis Introduction
11.25.4 Bioneer Corporation Revenue in Cancer Genome Analysis Business (2019-2024)
11.25.5 Bioneer Corporation Recent Development
11.26 Bio-Rad Laboratories, Inc
11.26.1 Bio-Rad Laboratories, Inc Company Detail
11.26.2 Bio-Rad Laboratories, Inc Business Overview
11.26.3 Bio-Rad Laboratories, Inc Cancer Genome Analysis Introduction
11.26.4 Bio-Rad Laboratories, Inc Revenue in Cancer Genome Analysis Business (2019-2024)
11.26.5 Bio-Rad Laboratories, Inc Recent Development
11.27 Bio-Techne
11.27.1 Bio-Techne Company Detail
11.27.2 Bio-Techne Business Overview
11.27.3 Bio-Techne Cancer Genome Analysis Introduction
11.27.4 Bio-Techne Revenue in Cancer Genome Analysis Business (2019-2024)
11.27.5 Bio-Techne Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Cancer Genome Analysis Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Solid Tissue Analysis
Table 3. Key Players of Liquid Tissue Analysis
Table 4. Global Cancer Genome Analysis Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Cancer Genome Analysis Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Cancer Genome Analysis Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Cancer Genome Analysis Market Share by Region (2019-2024)
Table 8. Global Cancer Genome Analysis Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Cancer Genome Analysis Market Share by Region (2025-2030)
Table 10. Cancer Genome Analysis Market Trends
Table 11. Cancer Genome Analysis Market Drivers
Table 12. Cancer Genome Analysis Market Challenges
Table 13. Cancer Genome Analysis Market Restraints
Table 14. Global Cancer Genome Analysis Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Cancer Genome Analysis Market Share by Players (2019-2024)
Table 16. Global Top Cancer Genome Analysis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Genome Analysis as of 2023)
Table 17. Ranking of Global Top Cancer Genome Analysis Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Cancer Genome Analysis Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Cancer Genome Analysis Product Solution and Service
Table 21. Date of Enter into Cancer Genome Analysis Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cancer Genome Analysis Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Cancer Genome Analysis Revenue Market Share by Type (2019-2024)
Table 25. Global Cancer Genome Analysis Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Cancer Genome Analysis Revenue Market Share by Type (2025-2030)
Table 27. Global Cancer Genome Analysis Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Cancer Genome Analysis Revenue Market Share by Application (2019-2024)
Table 29. Global Cancer Genome Analysis Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Cancer Genome Analysis Revenue Market Share by Application (2025-2030)
Table 31. North America Cancer Genome Analysis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Cancer Genome Analysis Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Cancer Genome Analysis Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Cancer Genome Analysis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Cancer Genome Analysis Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Cancer Genome Analysis Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Cancer Genome Analysis Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Cancer Genome Analysis Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Cancer Genome Analysis Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Cancer Genome Analysis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Cancer Genome Analysis Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Cancer Genome Analysis Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Cancer Genome Analysis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Cancer Genome Analysis Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Cancer Genome Analysis Market Size by Country (2025-2030) & (US$ Million)
Table 46. Abbott Diagnostics Company Detail
Table 47. Abbott Diagnostics Business Overview
Table 48. Abbott Diagnostics Cancer Genome Analysis Product
Table 49. Abbott Diagnostics Revenue in Cancer Genome Analysis Business (2019-2024) & (US$ Million)
Table 50. Abbott Diagnostics Recent Development
Table 51. AccuraGen Inc Company Detail
Table 52. AccuraGen Inc Business Overview
Table 53. AccuraGen Inc Cancer Genome Analysis Product
Table 54. AccuraGen Inc Revenue in Cancer Genome Analysis Business (2019-2024) & (US$ Million)
Table 55. AccuraGen Inc Recent Development
Table 56. Acuamark Diagnostics Company Detail
Table 57. Acuamark Diagnostics Business Overview
Table 58. Acuamark Diagnostics Cancer Genome Analysis Product
Table 59. Acuamark Diagnostics Revenue in Cancer Genome Analysis Business (2019-2024) & (US$ Million)
Table 60. Acuamark Diagnostics Recent Development
Table 61. Admera Health, LLC Company Detail
Table 62. Admera Health, LLC Business Overview
Table 63. Admera Health, LLC Cancer Genome Analysis Product
Table 64. Admera Health, LLC Revenue in Cancer Genome Analysis Business (2019-2024) & (US$ Million)
Table 65. Admera Health, LLC Recent Development
Table 66. Agena Bioscience, Inc Company Detail
Table 67. Agena Bioscience, Inc Business Overview
Table 68. Agena Bioscience, Inc Cancer Genome Analysis Product
Table 69. Agena Bioscience, Inc Revenue in Cancer Genome Analysis Business (2019-2024) & (US$ Million)
Table 70. Agena Bioscience, Inc Recent Development
Table 71. Agilent Company Detail
Table 72. Agilent Business Overview
Table 73. Agilent Cancer Genome Analysis Product
Table 74. Agilent Revenue in Cancer Genome Analysis Business (2019-2024) & (US$ Million)
Table 75. Agilent Recent Development
Table 76. Almac Diagnostics Company Detail
Table 77. Almac Diagnostics Business Overview
Table 78. Almac Diagnostics Cancer Genome Analysis Product
Table 79. Almac Diagnostics Revenue in Cancer Genome Analysis Business (2019-2024) & (US$ Million)
Table 80. Almac Diagnostics Recent Development
Table 81. Amoy Diagnostics Co., Ltd. Company Detail
Table 82. Amoy Diagnostics Co., Ltd. Business Overview
Table 83. Amoy Diagnostics Co., Ltd. Cancer Genome Analysis Product
Table 84. Amoy Diagnostics Co., Ltd. Revenue in Cancer Genome Analysis Business (2019-2024) & (US$ Million)
Table 85. Amoy Diagnostics Co., Ltd. Recent Development
Table 86. Anchor Dx Company Detail
Table 87. Anchor Dx Business Overview
Table 88. Anchor Dx Cancer Genome Analysis Product
Table 89. Anchor Dx Revenue in Cancer Genome Analysis Business (2019-2024) & (US$ Million)
Table 90. Anchor Dx Recent Development
Table 91. ANGLE plc Company Detail
Table 92. ANGLE plc Business Overview
Table 93. ANGLE plc Cancer Genome Analysis Product
Table 94. ANGLE plc Revenue in Cancer Genome Analysis Business (2019-2024) & (US$ Million)
Table 95. ANGLE plc Recent Development
Table 96. ApoCell, Inc. Company Detail
Table 97. ApoCell, Inc. Business Overview
Table 98. ApoCell, Inc. Cancer Genome Analysis Product
Table 99. ApoCell, Inc. Revenue in Cancer Genome Analysis Business (2019-2024) & (US$ Million)
Table 100. ApoCell, Inc. Recent Development
Table 101. ArcherDx, Inc Company Detail
Table 102. ArcherDx, Inc Business Overview
Table 103. ArcherDx, Inc Cancer Genome Analysis Product
Table 104. ArcherDx, Inc Revenue in Cancer Genome Analysis Business (2019-2024) & (US$ Million)
Table 105. ArcherDx, Inc Recent Development
Table 106. Asuragen Company Detail
Table 107. Asuragen Business Overview
Table 108. Asuragen Cancer Genome Analysis Product
Table 109. Asuragen Revenue in Cancer Genome Analysis Business (2019-2024) & (US$ Million)
Table 110. Asuragen Recent Development
Table 111. AVIVA Biosciences Company Detail
Table 112. AVIVA Biosciences Business Overview
Table 113. AVIVA Biosciences Cancer Genome Analysis Product
Table 114. AVIVA Biosciences Revenue in Cancer Genome Analysis Business (2019-2024) & (US$ Million)
Table 115. AVIVA Biosciences Recent Development
Table 116. Baylor Miraca Genetics Laboratories Company Detail
Table 117. Baylor Miraca Genetics Laboratories Business Overview
Table 118. Baylor Miraca Genetics Laboratories Cancer Genome Analysis Product
Table 119. Baylor Miraca Genetics Laboratories Revenue in Cancer Genome Analysis Business (2019-2024) & (US$ Million)
Table 120. Baylor Miraca Genetics Laboratories Recent Development
Table 121. Beckman Coulter, Inc. Company Detail
Table 122. Beckman Coulter, Inc. Business Overview
Table 123. Beckman Coulter, Inc. Cancer Genome Analysis Product
Table 124. Beckman Coulter, Inc. Revenue in Cancer Genome Analysis Business (2019-2024) & (US$ Million)
Table 125. Beckman Coulter, Inc. Recent Development
Table 126. Becton, Dickinson and Company Company Detail
Table 127. Becton, Dickinson and Company Business Overview
Table 128. Becton, Dickinson and Company Cancer Genome Analysis Product
Table 129. Becton, Dickinson and Company Revenue in Cancer Genome Analysis Business (2019-2024) & (US$ Million)
Table 130. Becton, Dickinson and Company Recent Development
Table 131. BGI Genomics Co. Ltd Company Detail
Table 132. BGI Genomics Co. Ltd Business Overview
Table 133. BGI Genomics Co. Ltd Cancer Genome Analysis Product
Table 134. BGI Genomics Co. Ltd Revenue in Cancer Genome Analysis Business (2019-2024) & (US$ Million)
Table 135. BGI Genomics Co. Ltd Recent Development
Table 136. Bioarray Genetics Company Detail
Table 137. Bioarray Genetics Business Overview
Table 138. Bioarray Genetics Cancer Genome Analysis Product
Table 139. Bioarray Genetics Revenue in Cancer Genome Analysis Business (2019-2024) & (US$ Million)
Table 140. Bioarray Genetics Recent Development
Table 141. Biocartis Company Detail
Table 142. Biocartis Business Overview
Table 143. Biocartis Cancer Genome Analysis Product
Table 144. Biocartis Revenue in Cancer Genome Analysis Business (2019-2024) & (US$ Million)
Table 145. Biocartis Recent Development
Table 146. Biocept, Inc Company Detail
Table 147. Biocept, Inc Business Overview
Table 148. Biocept, Inc Cancer Genome Analysis Product
Table 149. Biocept, Inc Revenue in Cancer Genome Analysis Business (2019-2024) & (US$ Million)
Table 150. Biocept, Inc Recent Development
Table 151. Biodesix Inc Company Detail
Table 152. Biodesix Inc Business Overview
Table 153. Biodesix Inc Cancer Genome Analysis Product
Table 154. Biodesix Inc Revenue in Cancer Genome Analysis Business (2019-2024) & (US$ Million)
Table 155. Biodesix Inc Recent Development
Table 156. BioFluidica Company Detail
Table 157. BioFluidica Business Overview
Table 158. BioFluidica Cancer Genome Analysis Product
Table 159. BioFluidica Revenue in Cancer Genome Analysis Business (2019-2024) & (US$ Million)
Table 160. BioFluidica Recent Development
Table 161. bioMérieux Diagnostics Company Detail
Table 162. bioMérieux Diagnostics Business Overview
Table 163. bioMérieux Diagnostics Cancer Genome Analysis Product
Table 164. bioMérieux Diagnostics Revenue in Cancer Genome Analysis Business (2019-2024) & (US$ Million)
Table 165. bioMérieux Diagnostics Recent Development
Table 166. Bioneer Corporation Company Detail
Table 167. Bioneer Corporation Business Overview
Table 168. Bioneer Corporation Cancer Genome Analysis Product
Table 169. Bioneer Corporation Revenue in Cancer Genome Analysis Business (2019-2024) & (US$ Million)
Table 170. Bioneer Corporation Recent Development
Table 171. Bio-Rad Laboratories, Inc Company Detail
Table 172. Bio-Rad Laboratories, Inc Business Overview
Table 173. Bio-Rad Laboratories, Inc Cancer Genome Analysis Product
Table 174. Bio-Rad Laboratories, Inc Revenue in Cancer Genome Analysis Business (2019-2024) & (US$ Million)
Table 175. Bio-Rad Laboratories, Inc Recent Development
Table 176. Bio-Techne Company Detail
Table 177. Bio-Techne Business Overview
Table 178. Bio-Techne Cancer Genome Analysis Product
Table 179. Bio-Techne Revenue in Cancer Genome Analysis Business (2019-2024) & (US$ Million)
Table 180. Bio-Techne Recent Development
Table 181. Research Programs/Design for This Report
Table 182. Key Data Information from Secondary Sources
Table 183. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Genome Analysis Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Cancer Genome Analysis Market Share by Type: 2023 VS 2030
Figure 3. Solid Tissue Analysis Features
Figure 4. Liquid Tissue Analysis Features
Figure 5. Global Cancer Genome Analysis Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Cancer Genome Analysis Market Share by Application: 2023 VS 2030
Figure 7. Clinical Case Studies
Figure 8. Pharmaceutical Case Studies
Figure 9. Research Case Studies
Figure 10. Cancer Genome Analysis Report Years Considered
Figure 11. Global Cancer Genome Analysis Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Cancer Genome Analysis Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Cancer Genome Analysis Market Share by Region: 2023 VS 2030
Figure 14. Global Cancer Genome Analysis Market Share by Players in 2023
Figure 15. Global Top Cancer Genome Analysis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Genome Analysis as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Cancer Genome Analysis Revenue in 2023
Figure 17. North America Cancer Genome Analysis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Cancer Genome Analysis Market Share by Country (2019-2030)
Figure 19. United States Cancer Genome Analysis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Cancer Genome Analysis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Cancer Genome Analysis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Cancer Genome Analysis Market Share by Country (2019-2030)
Figure 23. Germany Cancer Genome Analysis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Cancer Genome Analysis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Cancer Genome Analysis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Cancer Genome Analysis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Cancer Genome Analysis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Cancer Genome Analysis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Cancer Genome Analysis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Cancer Genome Analysis Market Share by Region (2019-2030)
Figure 31. China Cancer Genome Analysis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Cancer Genome Analysis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Cancer Genome Analysis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Cancer Genome Analysis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Cancer Genome Analysis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Cancer Genome Analysis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Cancer Genome Analysis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Cancer Genome Analysis Market Share by Country (2019-2030)
Figure 39. Mexico Cancer Genome Analysis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Cancer Genome Analysis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Cancer Genome Analysis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Cancer Genome Analysis Market Share by Country (2019-2030)
Figure 43. Turkey Cancer Genome Analysis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Cancer Genome Analysis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Abbott Diagnostics Revenue Growth Rate in Cancer Genome Analysis Business (2019-2024)
Figure 46. AccuraGen Inc Revenue Growth Rate in Cancer Genome Analysis Business (2019-2024)
Figure 47. Acuamark Diagnostics Revenue Growth Rate in Cancer Genome Analysis Business (2019-2024)
Figure 48. Admera Health, LLC Revenue Growth Rate in Cancer Genome Analysis Business (2019-2024)
Figure 49. Agena Bioscience, Inc Revenue Growth Rate in Cancer Genome Analysis Business (2019-2024)
Figure 50. Agilent Revenue Growth Rate in Cancer Genome Analysis Business (2019-2024)
Figure 51. Almac Diagnostics Revenue Growth Rate in Cancer Genome Analysis Business (2019-2024)
Figure 52. Amoy Diagnostics Co., Ltd. Revenue Growth Rate in Cancer Genome Analysis Business (2019-2024)
Figure 53. Anchor Dx Revenue Growth Rate in Cancer Genome Analysis Business (2019-2024)
Figure 54. ANGLE plc Revenue Growth Rate in Cancer Genome Analysis Business (2019-2024)
Figure 55. ApoCell, Inc. Revenue Growth Rate in Cancer Genome Analysis Business (2019-2024)
Figure 56. ArcherDx, Inc Revenue Growth Rate in Cancer Genome Analysis Business (2019-2024)
Figure 57. Asuragen Revenue Growth Rate in Cancer Genome Analysis Business (2019-2024)
Figure 58. AVIVA Biosciences Revenue Growth Rate in Cancer Genome Analysis Business (2019-2024)
Figure 59. Baylor Miraca Genetics Laboratories Revenue Growth Rate in Cancer Genome Analysis Business (2019-2024)
Figure 60. Beckman Coulter, Inc. Revenue Growth Rate in Cancer Genome Analysis Business (2019-2024)
Figure 61. Becton, Dickinson and Company Revenue Growth Rate in Cancer Genome Analysis Business (2019-2024)
Figure 62. BGI Genomics Co. Ltd Revenue Growth Rate in Cancer Genome Analysis Business (2019-2024)
Figure 63. Bioarray Genetics Revenue Growth Rate in Cancer Genome Analysis Business (2019-2024)
Figure 64. Biocartis Revenue Growth Rate in Cancer Genome Analysis Business (2019-2024)
Figure 65. Biocept, Inc Revenue Growth Rate in Cancer Genome Analysis Business (2019-2024)
Figure 66. Biodesix Inc Revenue Growth Rate in Cancer Genome Analysis Business (2019-2024)
Figure 67. BioFluidica Revenue Growth Rate in Cancer Genome Analysis Business (2019-2024)
Figure 68. bioMérieux Diagnostics Revenue Growth Rate in Cancer Genome Analysis Business (2019-2024)
Figure 69. Bioneer Corporation Revenue Growth Rate in Cancer Genome Analysis Business (2019-2024)
Figure 70. Bio-Rad Laboratories, Inc Revenue Growth Rate in Cancer Genome Analysis Business (2019-2024)
Figure 71. Bio-Techne Revenue Growth Rate in Cancer Genome Analysis Business (2019-2024)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock